Abstract
(Abstracted from Am J Obstet Gynecol 2017;216:259.e1–259.e6) Increasing concern that use of electric power morcellation during hysterectomy for benign conditions may result in the spread of an occult leiomyosarcoma (LMS) led the US Food and Drug Administration (FDA) to issue safety communications in April 2014 and November 2014, recommending that this procedure should not be used in perimenopausal and postmenopausal women. These communications significantly changed practice patterns of many gynecologic surgeons, increasing rates of abdominal hysterectomy (AH), and possibly resulting in more complications for patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
